Mark Hensley
Corporate Officer/Principal at VELOXIS PHARMACEUTICALS A/S
Mark Hensley active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Corporate Officer/Principal | 03/01/2019 | - |
| Sales & Marketing | 01/04/2016 | 03/01/2019 |
Career history of Mark Hensley
Training of Mark Hensley
| University of North Texas | Undergraduate Degree |
Statistics
International
| Denmark | 2 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 1 |
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Stock Market
- Insiders
- Mark Hensley
- Experience
